SPRAVATO® is the first new drug approved for depression by the Federal Drug Administration (FDA) in decades. SPRAVATO® is especially designed for those suffering from Treatment Resistant Depression (TRD). If you are currently diagnosed with depression and have not responded well to at least two different oral antidepressants, you may qualify for SPRAVATO®